Scientists from Poltreg published report with new data on laboratory technique increasing stability and quality of TREG preparation used in the treatment. The method is a subject of new patent application.
2017-05-01
May 2017
See other news
2023-06-15
PolTREG is expanding its cGMP capabilities, which are currently out-sourced, with the announcement of the completion of the first stage investment in and construction of its own state-of-the art cell and gene therapy manufacturing facility
2023-05-25
Prof. Piotr Trzonkowski, CEO of PolTREG has been awarded the Wprost Health Visioner 2023 Award
